Restoring health and curing disease through autophagy

PAQ Therapeutics focuses on developing innovative therapies that leverage its proprietary platform to enhance the delivery and efficacy of biologic drugs. The company employs a unique approach that combines advanced drug formulation techniques with targeted delivery systems, aiming to improve patient outcomes in various therapeutic areas. Their pipeline includes a range of product candidates designed to address unmet medical needs, particularly in the fields of oncology and autoimmune diseases.

The technology utilized by PAQ Therapeutics is centered around the optimization of drug stability and bioavailability, which is critical for the effectiveness of biologic therapies. By utilizing specialized formulations, the company aims to ensure that therapeutic agents remain stable and active within the body for extended periods. This approach not only enhances the therapeutic potential of existing drugs but also facilitates the development of new treatments that can be administered more effectively, ultimately leading to improved patient adherence and outcomes.

United States

PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring heath and curing disease through autophagy, the body's most versatile mechanism for natural cellular degradation. With our ATTEC (autophagosome-tethering compound) technology, we are developing a novel class of small molecule degraders capable of binding a diverse array of substrates to the autophagy pathway including proteins, aggregates, lipids, organelles and pathogens.  PAQ's research advances in this important new class of degradation therapies have the potential to fundamentally transform drug discovery and development.

PAQ Therapeutics

Company Details